Cargando…
Phenotypic Diversity of Breast Cancer-Related Mutations in Metalloproteinase-Disintegrin ADAM12
Six different somatic missense mutations in the human ADAM12 gene have been identified so far in breast cancer. Five of these mutations involve highly conserved residues in the extracellular domain of the transmembrane ADAM12-L protein. Two of these extracellular mutations, D301H and G479E, have bee...
Autores principales: | Qi, Yue, Duhachek-Muggy, Sara, Li, Hui, Zolkiewska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961381/ https://www.ncbi.nlm.nih.gov/pubmed/24651654 http://dx.doi.org/10.1371/journal.pone.0092536 |
Ejemplares similares
-
Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer
por: Duhachek-Muggy, Sara, et al.
Publicado: (2017) -
ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer
por: Duhachek-Muggy, Sara, et al.
Publicado: (2015) -
Alternative mRNA Splicing Generates Two Distinct ADAM12 Prodomain Variants
por: Duhachek-Muggy, Sara, et al.
Publicado: (2013) -
Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17
por: Yang, Guang, et al.
Publicado: (2021) -
The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas
por: Oh, S.-T., et al.
Publicado: (2016)